Pacira | PCRX - Net Income

Stock Price
22.69
Daily Change
0.42 1.89%
Monthly
2.02%
Yearly
-13.63%
Q2 Forecast
22.02

Pacira reported $1.64M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Assertio Holdings USD -2.92M 753K Sep/2024
Astellas Pharma JPY 100.38B 21.17B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Cara Therapeutics USD -5.53M 621K Sep/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.12B 36M Dec/2025
Ligand Pharmaceuticals USD 117.27M 112.43M Sep/2025
Nektar Therapeutics USD -36.08M 978K Dec/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Omeros USD -32.23M 23.81M Sep/2024
Pacira USD 1.64M 3.8M Dec/2025
Perrigo USD -1.42B 1.43B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024
Zoetis USD 603M 118M Dec/2025